Concepedia

Koen Andries

KA

130

Publications

17.5K

Citations

68

H-Index

1978

Active since

Affiliations

Janssen (Belgium)(Current)

Johnson & Johnson (United States)

KU Leuven

Janssen (United States)

Johnson & Johnson (France)

Koen Andries is an author at Janssen (Belgium) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1978–2023

130

Publications

130

A Diarylquinoline Drug Active on the ATP Synthase of <i>Mycobacterium tuberculosis</i>

Koen Andries, Peter Verhasselt, Jérôme Guillemont et al. · Science · 2004 · 2.1K citations · Full text

, , +18

The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis

Andreas H. Diacon, Alexander S. Pym, Martin P. Grobusch et al. · New England Journal of Medicine · 2009 · 836 citations · Full text

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

Rudi Pauwels, Koen Andries, Jan Desmyter et al. · Nature · 1990 · 754 citations

, , +11

Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline

Andreas H. Diacon, Alexander S. Pym, Martin P. Grobusch et al. · New England Journal of Medicine · 2014 · 732 citations · Full text

Diarylquinolines target subunit c of mycobacterial ATP synthase

Anil Koul, Najoua Dendouga, Karen Vergauwen et al. · Nature Chemical Biology · 2007 · 537 citations · Full text

, , +5

Rows per page

1–5 of 130